Aterocon LA Capsules

Aterocon LA Capsules

S6


Clinical Summary

Quick overview from the medicine insert

Indication

Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy.

Dosage (summary)

Initial dose for ADHD is typically 5 mg once or twice daily, with gradual increments based on clinical response, not exceeding 60 mg per day.

Onset of Action / Duration

Effects may be observed within 30 to 60 minutes after administration, with a duration of action of 3 to 6 hours for immediate-release formulations.

Special Populations

  • Pediatric patients
  • Geriatric patients
  • Patients with cardiovascular disorders
  • Patients with a history of substance abuse

Pregnancy & Breastfeeding

Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Methylphenidate is excreted in breast milk; caution is advised when administered to nursing mothers.

Key Drug Interactions

  • Monoamine oxidase inhibitors (MAOIs)
  • Antidepressants (especially SSRIs and SNRIs)
  • Antihypertensives
  • Anticonvulsants

Contraindications

  • Hypersensitivity to methylphenidate or any component of the formulation
  • Severe anxiety, tension, or agitation
  • Glaucoma
  • Tic disorders or family history of Tourette's syndrome
  • Severe cardiovascular disorders

Common side effects

  • Insomnia
  • Decreased appetite
  • Nausea
  • Headache
  • Irritability
  • Increased heart rate
  • Hypertension

Counselling Points

  • Take as prescribed, do not exceed the recommended dose.
  • Monitor for changes in mood or behavior.
  • Avoid alcohol and other CNS stimulants.
  • Report any signs of cardiovascular issues immediately.
  • Store in a cool, dry place away from children.

Serious warnings

  • Potential for abuse and dependence.
  • Monitor growth in pediatric patients.
  • May exacerbate pre-existing psychiatric disorders.
  • Caution in patients with a history of seizures.
Important Disclaimer

The Aterocon LA Capsules professional information leaflet below is the property of Austell Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites